Arvinas (ARVN) Interest Expenses (2017 - 2026)

Arvinas' (ARVN) quarterly Interest Expenses came in at $3.9 million in Q1 2026, down 66.95% year-on-year from $11.8 million in Q1 2025, and up 875.0% quarter-over-quarter from $400000.0 in Q4 2025.

Arvinas (ARVN) Interest Expenses (2017 - 2026) Analysis & Trends

Arvinas' Interest Expenses history runs 10 years deep, the most recent figure standing at $3.9 million for Q1 2026.

  • On a quarterly basis, Interest Expenses fell 66.95% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a 66.95% decrease from a year earlier, with the FY2025 full-year figure at $481.4 million, up 2.12% from the prior year.
  • Interest Expenses advanced to $3.9 million in Q1 2026 per ARVN's latest filing, from $400000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $11.8 million in Q1 2025 and bottomed at $400000.0 in Q4 2022.
  • The 5-year median for Interest Expenses is $2.5 million (2025), against an average of $3.0 million.
  • Across the five-year window, Interest Expenses plunged 99.75% in 2022 and surged 640.0% in 2023, its largest moves.
  • Year by year, Interest Expenses stood at $400000.0 in 2022, then grew by 25.0% to $500000.0 in 2023, then soared by 260.0% to $1.8 million in 2024, then slumped by 77.78% to $400000.0 in 2025, then soared by 875.0% to $3.9 million in 2026.
  • Per Business Quant, the three latest ARVN Interest Expenses figures stand at $3.9 million (Q1 2026), $400000.0 (Q4 2025), and $2.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Arvinas 519.68 Mn -95.22 Mn - 3.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.90 Mn
Mar 31, 2026 3.90 Mn
Dec 31, 2025 400,000.00
Dec 31, 2025 400,000.00
Sep 30, 2025 2.50 Mn
Sep 30, 2025 2.50 Mn
Jun 30, 2025 2.50 Mn
Jun 30, 2025 2.50 Mn
Mar 31, 2025 11.80 Mn
Mar 31, 2025 11.80 Mn
Dec 31, 2024 1.80 Mn
Dec 31, 2024 1.80 Mn
Sep 30, 2024 900,000.00
Sep 30, 2024 900,000.00
Jun 30, 2024 1.40 Mn
Jun 30, 2024 1.40 Mn
Mar 31, 2024 2.00 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 500,000.00
Dec 31, 2023 500,000.00